Suppr超能文献

Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.

作者信息

Sriboonnark Theeratach, Boonsopon Sutasinee, Tesavibul Nattaporn, Leeamornsiri Supinda, Choopong Pitipol

机构信息

Department of Ophthalmology, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Department of Ophthalmology, Thammasat University Hospital, Pathumthani 12120, Thailand.

出版信息

Int J Ophthalmol. 2017 Oct 18;10(10):1627-1629. doi: 10.18240/ijo.2017.10.25. eCollection 2017.

Abstract
摘要

相似文献

1
Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.
Int J Ophthalmol. 2017 Oct 18;10(10):1627-1629. doi: 10.18240/ijo.2017.10.25. eCollection 2017.
3
Intravitreal injection of bevacizumab in Eales disease.
Ocul Immunol Inflamm. 2008 Jan-Feb;16(1):63-5. doi: 10.1080/09273940801923903.
7
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Ophthalmology. 2006 Oct;113(10):1695.e1-15. doi: 10.1016/j.ophtha.2006.05.064.
8
Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Am J Ophthalmol. 2010 Jun;149(6):964-972.e1. doi: 10.1016/j.ajo.2010.01.008. Epub 2010 Apr 9.
9
Visual acuity recovery in a case of idiopathic retinal vasculitis aneurysms and neuroretinitis.
Optom Vis Sci. 2012 Mar;89(3):E356-63. doi: 10.1097/OPX.0b013e3182429c53.
10
Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.
J AAPOS. 2014 Apr;18(2):120-3. doi: 10.1016/j.jaapos.2013.12.009.

引用本文的文献

1
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis.
Front Immunol. 2021 Oct 20;12:733853. doi: 10.3389/fimmu.2021.733853. eCollection 2021.

本文引用的文献

1
Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report.
Int Med Case Rep J. 2017 Apr 18;10:139-141. doi: 10.2147/IMCRJ.S128885. eCollection 2017.
2
3
Ocular tuberculosis: current perspectives.
Clin Ophthalmol. 2015 Nov 26;9:2223-7. doi: 10.2147/OPTH.S65254. eCollection 2015.
4
The role of anti-tubercular therapy in patients with presumed ocular tuberculosis.
Ocul Immunol Inflamm. 2015 Feb;23(1):40-6. doi: 10.3109/09273948.2014.986584.
5
Clinics of ocular tuberculosis.
Ocul Immunol Inflamm. 2015 Feb;23(1):14-24. doi: 10.3109/09273948.2014.986582.
6
Ischemic retinal vasculitis and its management.
J Ophthalmol. 2014;2014:197675. doi: 10.1155/2014/197675. Epub 2014 Apr 15.
9
Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization.
Clin Ophthalmol. 2012;6:1233-7. doi: 10.2147/OPTH.S34294. Epub 2012 Aug 1.
10
Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.
Br J Ophthalmol. 2012 Mar;96(3):332-6. doi: 10.1136/bjophthalmol-2011-300209. Epub 2011 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验